Elevation Oncology, Inc.
ELEV · NASDAQ
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$14,211 | -$10,436 | -$12,881 | -$10,461 |
| Dep. & Amort. | $5 | $5 | $5 | $4 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $987 | $1,177 | $1,154 | $1,047 |
| Change in WC | $642 | -$675 | $3,674 | $1,445 |
| Other Non-Cash | -$134 | -$273 | -$334 | -$240 |
| Operating Cash Flow | -$12,711 | -$10,202 | -$8,382 | -$8,205 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$8,205 | $8,205 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | -$9,032 | -$13,573 | -$46,960 |
| Inv. Sales/Matur. | $23,758 | $20,500 | $10,700 | $9,300 |
| Other Inv. Act. | $0 | $0 | $8,205 | -$8,205 |
| Investing Cash Flow | $23,758 | $11,468 | -$2,873 | -$37,660 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $0 | $14,551 |
| Stock Repurch. | -$17 | -$4 | -$2 | -$16 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $0 | $12 | $147 |
| Financing Cash Flow | -$17 | -$4 | $10 | $14,682 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $11,030 | $1,262 | -$11,245 | -$31,183 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $49,464 | $48,202 | $59,447 | $90,630 |
| End Cash | $60,494 | $49,464 | $48,202 | $59,447 |
| Free Cash Flow | -$12,711 | -$10,202 | -$8,382 | $0 |